ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "HLA antibodies"

  • 2017 American Transplant Congress

    Biological Interplay Between Circulating HLA-sp Alloreactive Memory B-Cells and Long-Lived Plasma Cells in Kidney Transplant Patients Undergoing Chronic ABMR.

    S. Luque,2 M. Lúcia,4 M. Jarque,2 E. Crespo,2 E. Melilli,1 J. Martorell,3 J. Cruzado,1,2 J. Torras,1,2 J. Grinyó,1,2 O. Bestard.1,2

    1Kidney Transplant Unit, Bellvitge University Hospital, Barcelona, Spain; 2Experimental Nephrology Laboratory, IDIBELL, Barcelona, Spain; 3Immunogenetics Laboratory, Hospital Clínic, Barcelona, Spain; 4Transplant Immunology, School of Medicine, Stanford

    Alloreactive humoral responses are one of the main causes of immune-mediated allograft injury in kidney transplantation. Different biological compartments are involved in the generation and…
  • 2017 American Transplant Congress

    Meta-Analysis of Clinical Significance of Complement Activating Anti-HLA DSA in Kidney Transplantation.

    A. Bouquegneau,1,2 C. Ulloa,1 O. Aubert,1 C. Loheac,1 D. Viglietti,1 J. Empana,1 P. Jabre,1 X. Jouven,1 C. Lefaucheur,1 A. Loupy.1

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2Department of Nephrology, Dialysis and Transplantation, Liège, Belgium

    Donor-specific anti-HLA antibodies (DSA) are currently recognized as the major limitation to access transplantation and the first cause of late transplant failures. The effect of…
  • 2017 American Transplant Congress

    Assessing the Impact of the New KAS on Transplant Rates in Highly-HLA Sensitized (HS) Patients After Desensitization (Des) 2 Years Post Implementation.

    A. Vo,1 S. Williamson,1 K. Myers,1 E. Huang,1 J. Choi,1 X. Zhang,2 A. Peng,1 R. Najjar,1 S. Jordan.1

    1Kidney Transplant, Cedars-Sinai Medical Center, LA, CA; 2HLA Laboratory, Cedars-Sinai Medical Center, LA, CA

    Introduction: The new KAS aims to improve access to transplantation for HS patients, specifically CPRA 99-100%. Our center has extensive experience w. DES to improve…
  • 2017 American Transplant Congress

    De Novo Donor-Specific Antibody Formation After Kidney Retransplant Is Associated with Specificity Against Class I.

    K. Atiemo,1 B. Ho,1 H. Bhagat,2 E. Lee,2,3 A. Daud,1 R. Kang,1 S. Montag,1,4 L. Zhao,1,4 J. Schwartz,2 D. Ladner.1

    1Northwestern University Transplant and Outcomes Research Collaborative (NUTORC), Chicago; 2Astellas Pharma Global Development, Northbrook; 3Now with UCB, Atlanta; 4Dept of Preventive Medicine, Northwestern University, Chicago

    Retransplant (RTx) patients are often sensitized due to donor-specific antibody (DSA) formation, with higher acute rejection rates during subsequent transplants vs patients without DSA. However,…
  • 2017 American Transplant Congress

    Patient Outcomes Following the Disappearance of Donor Specific Antibody in Crossmatch Positive Simultaneous Liver-Kidney Transplant Recipients.

    P. Jindra,1 G. Stacie,1 A. Rana,2 C. O'Mahony,2 J. Goss,2 M. Bhamidipati,2 E. Whiston,3 R. Kerman.1

    1Michael E. DeBakey Department of Surgery Division of Abdominal Transplant and Immune Evaluation Lab, Baylor College of Medicine, Houston, TX; 2Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation and Division of Hepatobiliary Surgery, Baylor College of Medicine, Houston, TX; 3Department of Transplant Nephrology, Baylor St Luke's Medical Center, Houston, TX

    Background: Simultaneous liver and kidney transplantation (SLKT) remains as the gold standard for patients with chronic renal and liver diseases. Pre-transplant donor-specific antibody (DSA) to…
  • 2017 American Transplant Congress

    A Novel 3-Dimensional Culture System Enables In Vitro Study of Human Bone Marrow Plasma Cells.

    J. Driscoll,1 S. Tremblay,2 S. Knechtle,3 E. Woodle.2

    1Medicine, Univ Cincinnati, Cincinnati, OH; 2Surgery, Univ Cincinnati, Cincinnati, OH; 3Transplant, Duke Univ, Durham, NC

    Purpose: Historically, in vitro study of human plasma cells (PCs) has been greatly limited by their short survival (48-72 hrs). Therefore, systems that maintain viability…
  • 2017 American Transplant Congress

    Donor-Specific B Cell Responses: Predicting the Future of Kidney Transplants.

    M. Cascalho,1 E. Farkash,2 L. Adam,1 M. Samaniego,3 J. Platt.

    1Surgery, University of Michigan, Ann Arbor; 2Pathology, University of Michigan, Ann Arbor; 3Internal Medicine, University of Michigan, Ann Arbor

    Allogeneic cell and tissue transplants nearly always evoke B cell responses ascertainable by detecting donor-specific antibodies (DSA) in the circulation of the recipient. DSA are…
  • 2017 American Transplant Congress

    Prognostic Tools to Choose Candidates for Successful Desensitization.

    D. Pinelli,1 A. Zachary,2 J. Friedewald,1 M. Leffell,2 D. Lucas,2 R. Montgomery,2 A. Tambur.1

    1Northwestern University, Chicago, IL; 2Johns Hopkins, Baltimore, MD

    Antibodies to donor HLA antigens are a barrier to solid organ transplantation. Strategies to desensitize patients have improved, but the ability to predict response to…
  • 2017 American Transplant Congress

    Renal Transplant Patient Outcomes Following Plasmapheresis, Thymoglobulin, and Rituximab Induction for High Risk DSA Positive Recipients.

    E. Lessmann,1 M. Moaddab,1 M. Manson,1 A. Ram,2 R. Kerman,2 P. Jindra.2

    1Pharmacy, CHI St. Luke's Health Baylor St. Luke's Medical Center, Houston, TX; 2Immune Evaluation Laboratory, Baylor College of Medicine, Houston, TX

    Background: Kidney transplantation is associated with improved survival and quality of life relative to dialysis for patients with end-stage renal disease (ESRD). Patients who are…
  • 2017 American Transplant Congress

    Limited Impact of Pre-Existing Donor Specific HLA Antibodies on Long Term Survival After First Adult Liver Transplantation.

    M. Koch,1 M. Marget,2 M. Sterneck,3 H. Thude,1 B. Nashan.1

    1Hepatobiliary Surgery and Transplantation, University Hospital Hamburg Eppendorf, Hamburg, Germany; 2Transfusion Medicine, University Hospital Hamburg Eppendorf, Hamburg, Germany; 3Internal Medicine I, Gastroenterology, University Hospital Hamburg Eppendorf, Hamburg, Germany

    Donor specific antibodies (DSA) are known to play a pivotal role in long term kidney allograft survival. Their importance in liver transplanted patients (LTX) is…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 47
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences